Musculoskeletal Report: Results

January 04, 2011

Home
About Us
Events
- EULAR 2009
- ISEMIR 2009
- RWCS 2009
- ACR 2008
- EULAR 2008
- AAOS 2008
- ISEMIR 2008
- ACR 2007
- ASBMR 2007
- EULAR 2007
- GARN 2007
- LUPUS 2007
- EULAR 2006
- ACR 2006
- ORS 2006
- OARSI 2006
CME
- CME News
- CME Opportunities
Publications
- Journals
- Newsletters

News Categories Arthritis Autoimmunity BioPharm Business Bones Consumer News Imaging Pain Procedures Skin Spondyloarthropathies

Meeting Highlights

ISEMIR 2009: Video coverage of the Meeting
Miami, March 27, 2009

RWCS 2009: Video coverage of the Symposium
Maui, January 14-17, 2009

ACR 2008: News from the Annual Scientific Meeting
San Francisco, October 24-29, 2008

EULAR 2008: Coverage of the Congress
Paris, June 11-14, 2008

ISEMIR 2008: Video coverage of the Meeting
Chicago, April 10, 2008

AAOS 2008: News from the Annual Meeting
San Francisco, March 5-9, 2008

Affiliations

Lupus Research Institute - Letting Science Lead the Way to a Cure

Related Articles Results

Found 2 result(s) FROM 1963 pages containing the term 'osteopontin'.

Monday Jul 23, 2007
Elan, Biogen Idec to Appeal Negative Ruling on European Application for Tysabri^R for Crohn's

Elan Corporation, plc, and Biogen Idec announced that they have been informed by the European Medicines Agency that the Committee for Medicinal Products for Human Use has adopted a negative opinion on the marketing application for the use of Tysabri® (natalizumab).

Wednesday Mar 22, 2006
Inhibiting Osteopontin May Stave Off Wear Debrisâ€“Induced Osteolysis
Inhibiting the bone-specific protein osteopontin may prevent wear debrisâ€“induced osteolysis... Shimizu S, et al. Presented at: 52nd Annual Meeting of the Orthopaedic Research Society; March 18â€“22, 2006; Chicago, Ill. Abstract 92.

News Categories:

Events:

CME:

CME News Articles | CME Opportunities

Publications:

Journals | Newsletters

About Us: